This effect is mainly used to compensate for the chronic progressive loss of neurons in different regions of the brain.
| NO. | PubChem ID | CAS Number | Molecular Name | Efficacy | Efficacy_Chinese |
|---|---|---|---|---|---|
| 101 | 155569 | 0 | [8-acetyloxy-11-ethyl-5,14-dihydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecan-4-yl] 4-methoxybenzoate | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 102 | 155948 | 73030-71-4 | (4aS,8aR,9aS)-9a-hydroxy-3,8a-dimethyl-5-methylidene-4,4a,6,7,8,9-hexahydrobenzo[f][1]benzofuran-2-one | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 103 | 156709 | 76494-51-4 | 2,3,5,6-tetramethylpyrazine;hydrochloride | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 104 | 157672 | 25162-00-9 | 3-[(2R)-1-methylpyrrolidin-2-yl]pyridine | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 105 | 161362 | 21499-24-1 | (3S)-6,8-dihydroxy-3-[2-(4-methoxyphenyl)ethyl]-3,4-dihydroisochromen-1-one | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 106 | 164676 | 568-72-9 | 1,6,6-trimethyl-8,9-dihydro-7H-naphtho[1,2-g][1]benzofuran-10,11-dione | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 107 | 185617 | 27740-01-8 | (2S,3S,4S,5R,6S)-6-[5,6-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 108 | 192462 | 0 | (3R,8S,9S,10R,13S,14S,17S)-17-[(1S)-1-(dimethylamino)ethyl]-N,10,13-trimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 109 | 222064 | 0 | 2,2-dimethyl-3,4-dihydrochromene-6-carboxylic acid | anti-neurodegenerative diseases | 抗神经退行性疾病 |
| 110 | 225688 | 0 | 4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol | anti-neurodegenerative diseases | 抗神经退行性疾病 |